Literature DB >> 25185833

Albuminuria and hypertension: the chicken or the egg?

Yasuyuki Nagasawa1, Yukiko Hasuike1, Masayoshi Nanami1, Takahiro Kuragano1, Takeshi Nakanishi1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25185833     DOI： 10.1038/hr.2014.135

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  26 in total

Review 1.  The glomerular endothelium: new insights on function and structure.

Authors:  Börje Haraldsson; Jenny Nyström
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

2.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

Authors:  T Konta; Z Hao; H Abiko; M Ishikawa; T Takahashi; A Ikeda; K Ichikawa; S Takasaki; I Kubota
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

3.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

4.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

Review 5.  The proximal tubule and albuminuria: really!

Authors:  Landon E Dickson; Mark C Wagner; Ruben M Sandoval; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

6.  Increases in urinary albumin and beta2-microglobulin are independently associated with blood pressure in the Japanese general population: the Takahata Study.

Authors:  Yusuke Mashima; Tsuneo Konta; Kosuke Kudo; Satoshi Takasaki; Kazunobu Ichikawa; Kazuko Suzuki; Yoko Shibata; Tetsu Watanabe; Takeo Kato; Sumio Kawata; Isao Kubota
Journal:  Hypertens Res       Date:  2011-04-28       Impact factor: 3.872

7.  Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.

Authors:  A Kuwabara; M Satoh; N Tomita; T Sasaki; N Kashihara
Journal:  Diabetologia       Date:  2010-06-06       Impact factor: 10.122

Review 8.  Treatment and impact of dyslipidemia in diabetic nephropathy.

Authors:  Tadashi Toyama; Miho Shimizu; Kengo Furuichi; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-11-07       Impact factor: 2.801

9.  Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.

Authors:  Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Journal:  Am J Kidney Dis       Date:  2010-01-25       Impact factor: 8.860

10.  Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program.

Authors:  Adam Whaley-Connell; Brian S Pavey; Peter A McCullough; Georges Saab; Suying Li; Samy I McFarlane; Shu-Cheng Chen; Joseph A Vassalotti; Allan J Collins; George Bakris; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-01       Impact factor: 3.738
View more
  2 in total

1.  White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.

Authors:  Jun Hata; Masayo Fukuhara; Satoko Sakata; Hisatomi Arima; Yoichiro Hirakawa; Koji Yonemoto; Naoko Mukai; Takanari Kitazono; Yutaka Kiyohara; Toshiharu Ninomiya
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

2.  Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.

Authors:  Yasuyuki Nagasawa; Ryohei Yamamoto; Tatsuya Shoji; Maki Shinzawa; Yukiko Hasuike; Katsuyuki Nagatoya; Atsushi Yamauchi; Terumasa Hayashi; Takayuki Kuragano; Toshiki Moriyama; Yoshitaka Isaka; Takeshi Nakanishi
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.